Thomas et al., 2000 [53] |
case control |
29 + 18 |
migraine + control |
significantly lower concentrations of total Mg in erythrocytes and lymphocytes in migraine |
Mg in lymphocytes appears to be the most sensitive index of Mg deficiency |
Trauninger et.al. 2002 [54] |
case control |
20 + 20 |
migraine + healthy |
no significant difference between the groups in the baseline serum and urine Mg concentrations, although the latter tended to be lower in the migraine |
Mg retention occurs in patients with migraine after oral loading, suggesting a systemic Mg deficiency |
Talebi et al., 2011 [55] |
case control |
140 + 140 |
migraine + healthy |
the average serum Mg level in migraine was significantly lower, no significant difference between the mean level of serum Mg in migraine with aura and without aura |
serum Mg in migraine patients was related to the frequency of migraine attacks, supporting the use of Mg in prevention and treatment of migraine |
Samaie et al., 2012 [56] |
case control |
50 + 50 |
migraine + healthy |
no significant differences, but serum total Mg level was notably lower in the migraine |
assessing serum Mg level might predict migraine attacks and help to determine optimal dose of administered Mg for achieving appropriate therapeutic outcome |
Assarzadegan et al., 2016 [57] |
case control |
40 + 40 |
migraine + healthy |
significant lower Mg serum levels during the migraine attacks and between the attacks compared with healthy individuals |
the serum level of Mg is an independent factor for migraine |
Karim et al., 2021 [58] |
cross-sectional analytical |
70 |
migraine |
serum Mg level lower in severe migraine in comparison to mild to moderate headache |
in all migraine groups Mg within normal range |
Pfaffenrath et al., 1996 [61] |
double-blind placebo-controlled study |
150 |
migraine |
with regard to the number of migraine days or migraine attacks there was no benefit with Mg compared to placebo |
there were no centre-specific differences, and the final assessments of treatment efficacy by the doctor and patient were largely equivocal |
Walker et al., 2003 [62] |
randomised double-blind placebo-controlled parallel |
46 |
healthy |
supplementation of the organic forms of Mg citrate and amino-acid chelate showed greater absorption than Mg oxide |
supplementation with Mg citrate shows superior bioavailability |
Karimi et al., 2021 [63] |
single-center, randomized, controlled, double-blind, crossover |
31 + 32 |
migraine + control |
Mg oxide vs valproate sodium did not show statistically significant difference in the efficacy of both drugs in migraine preventive |
Mg oxide can be equally effective in the prevention of migraine attacks as valproate sodium, additionally without significant side effects |
Wang et al., 2003 [65] |
randomized, double-blind, placebo-controlled, parallel-group |
58 + 60 children of ages 3 to 17 years |
migraine + control |
a statistically significant downward trend in the frequency and severity of migraine pain was found in the group treated with Mg oxide but not in the placebo group |
the study is inconclusive |
Morel et al., 2021 [66] |
systematic review of RCT |
81 RCTs on Mg treatment in pain (18 RCTs in migraine) |
different types of pain, including migraine |
the greatest number of RCTs covering this issue was found in post-operative pain and migraine treated Mg |
additional, programmed clinical trials are needed to achieve a sufficient level of scientific evidence to recommend and optimize the use of magnesium in the treatment of pain, mainly chronic pain |
Lindberg et al., 1990 [67] |
observational |
17 |
healthy |
the level of Mg in urine after an oral loading with two Mg salts - higher after Mg citrate than Mg oxide |
Mg citrate is more soluble and bioavailable than Mg oxide |
Muehlbauer et al., 1991 [68] |
observational |
24 |
healthy |
Mg-oxide showed significantly lower absorption than Mg-l-aspartate-HCI (granules/tablets) |
Mg-l-aspartate-HCI appear to be the first choice for Mg substitution |
Khani et al., 2021 [69] |
randomized single-center double-blind parallel-group controlled |
82 + 70 + 70 (sodium valproate + magnesium with sodium valproate + magnesium) |
migraine |
significant reduction of migraine in valproate with Mg group |
Mg enhance the antimigraine properties of sodium valproate in combination therapy and reduce the required valproate dose for migraine prophylaxis |
Gallelli et al., 2014 [71] |
single-blinded, balanced-recruitment, parallel-group, single-center |
116 children of ages 5–16 |
migraine |
Mg, acetaminophen, ibuprofen decreased pain intensity, but did not modify its frequency; in both acetaminophen and ibuprofen groups, magnesium significantly reduced the pain frequency |
Mg increased the efficacy of ibuprofen and acetaminophen with not age-related effects |
Slavin et al., 2021 [72] |
cross-sectional |
3626 |
migraine or sever headache |
Mg consumption associated with lower odds of migraine |
evaluate the role of dietary Mg intake on migraine |